Antineoplastic And Immunomodulating Agents – Cytostatics, Immunomodulators And Endocrine Therapy 2024. Cytostatic And Containing The Active Ingredient Niraparib,Cytostatic Agent Containing The Active Substance Tebentafusp,Immunosuppressant Containing The Active Substance Ozanimod,Hormonal Drug Containing The Active Substance Etelcalcetide,Hormonal Drug Containing The Active Substance Follitropin Alfa,Cytostatic Drug Containing The Active Ingredient Degarelix,Immunosuppressant Containing The Active Substance Filgotinib,Immunosuppressant Containing The Active Substance Bimekizumab,Immunosuppressant Containing The Active Substance Tildrakizumab,Hormonal Drug Containing The Active Substance Triptorelin,Cytostatic Agent Containing The Active Substance Avapritinib,Immunosuppressant Containing The Active Ingredient Pegcetacoplan,Immunosuppressant Containing The Active Substance Tocilizumab,Cytostatic Drug Containing The Active Substance Tepotinib,Immunosuppressant Containing The Active Ingredient Ravulizumab,Cytostatic Agent Containing The Active Ingredient Loncastuximab Tesirin
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
